Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7084)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2021 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chung MW, Kim MJ, Won EJ, Lee YJ, Yun YW, Cho SB, Joo YE, Hwang JE, Bae WK, Chung IJ, Shin MG, Shin JH. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients. World J Gastroenterol 2021; 27(42): 7340-7349 [PMID: 34876793 DOI: 10.3748/wjg.v27.i42.7340] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i42/7340.htm |
| Number | Citing Articles |
| 1 |
Casey Finnicum, Zahraa Rahal, Maya Hassane, Warapen Treekitkarnmongkol, Ansam Sinjab, Rhiannon Morris, Yuejiang Liu, Elizabeth Tang, Sarah Viet, Jason Petersen, Philip Lorenzi, Lin Tan, Joseph Petrosino, Kristi Hoffman, Junya Fujimoto, Seyed Moghaddam, Humam Kadara. Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes. International Journal of Molecular Sciences 2022; 23(18): 10930 doi: 10.3390/ijms231810930
|
| 2 |
Deniz Can Guven, Taha Koray Sahin, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Kazim Sahin. The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges. Applied Sciences 2022; 12(20): 10548 doi: 10.3390/app122010548
|
| 3 |
Niels Schaft, Jan Dörrie, Gerold Schuler, Beatrice Schuler-Thurner, Husam Sallam, Shiri Klein, Galit Eisenberg, Shoshana Frankenburg, Michal Lotem, Areej Khatib. The future of affordable cancer immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1248867
|
| 4 |
Paola Muscolino, Barbara Granata, Fausto Omero, Claudia De Pasquale, Stefania Campana, Alessia Calabrò, Federica D’Anna, Fabiana Drommi, Gaetana Pezzino, Riccardo Cavaliere, Guido Ferlazzo, Nicola Silvestris, Desirèe Speranza. Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1247614
|
| 5 |
Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, Yehia I. Mohamed, Michael LaPelusa, Sunyoung S. Lee, Zishuo Ian Hu, Eugene J. Koay, Hop S. Tran Cao, Prasun Kumar Jalal, Carrie Daniel-MacDougall, Manal Hassan, Dan G. Duda, Hesham M. Amin, Ahmed O. Kaseb. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Cancers 2023; 15(19): 4875 doi: 10.3390/cancers15194875
|
| 6 |
Mo Cheng, Xiufeng Zheng, Jing Wei, Ming Liu. Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review). Experimental and Therapeutic Medicine 2023; 26(6) doi: 10.3892/etm.2023.12285
|
| 7 |
Eun Jeong Won, Yu Jeong Lee, Moon-Ju Kim, Tae-Jong Kim, Hong-Joon Shin, Tae-Ok Kim, Yong-Soo Kwon, Frederick Quinn. Lower respiratory tract microbiota in patients with clinically suspected nontuberculous mycobacterial pulmonary disease according to the presence of gastroesophageal reflux. PLOS ONE 2024; 19(8): e0309446 doi: 10.1371/journal.pone.0309446
|
| 8 |
Jiaao Sun, Feng Chen, Guangzhen Wu. Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy. The ISME Journal 2023; 17(10): 1535 doi: 10.1038/s41396-023-01483-0
|
| 9 |
Lydie Sparfel, Sandy Ratodiarivony, Elisa Boutet‐Robinet, Sandrine Ellero‐Simatos, Anne Jolivet‐Gougeon. Akkermansia muciniphila and Alcohol‐Related Liver Diseases. A Systematic Review. Molecular Nutrition & Food Research 2024; 68(2) doi: 10.1002/mnfr.202300510
|
| 10 |
Mengwei Zhang, Jinkai Liu, Qiang Xia. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Experimental Hematology & Oncology 2023; 12(1) doi: 10.1186/s40164-023-00442-x
|
| 11 |
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati Baroni, Maria Eva Argenziano, Francesca Giorgi, Giuseppe Guido Maria Scarlata, Francesca Ponziani, Emidio Scarpellini. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors. Medicina 2023; 59(8): 1427 doi: 10.3390/medicina59081427
|
| 12 |
Hsiang-Chun Lai, Hung-Jen Lin, Ying-Hsiu Shih, Jen-Wei Chou, Kuan-Wen Lin, Long-Bin Jeng, Sheng-Teng Huang. LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study. World Journal of Gastrointestinal Oncology 2023; 15(5): 828-842 doi: 10.4251/wjgo.v15.i5.828
Abstract(430) |
Core Tip(430) |
Full Article(HTML)(1628)
|
Full Article (PDF)-880K(105)
|
Full Article (Word)-265K(27)
|
Audio-914K(2)
|
Peer-Review Report-249K(41)
|
Answering Reviewers-92K(45)
|
Times Cited (0)
|
Total Visits (4677)
|
Open
|
| 13 |
Zehua Li, Weixi Xiong, Zhu Liang, Jinyu Wang, Ziyi Zeng, Damian Kołat, Xi Li, Dong Zhou, Xuewen Xu, Linyong Zhao. Critical role of the gut microbiota in immune responses and cancer immunotherapy. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01541-w
|
| 14 |
Alexandra D. Ladd, Sergio Duarte, Ilyas Sahin, Ali Zarrinpar. Mechanisms of drug resistance in HCC. Hepatology 2023; doi: 10.1097/HEP.0000000000000237
|
| 15 |
Efstathia Davoutis, Zoi Gkiafi, Panagis M Lykoudis. Bringing gut microbiota into the spotlight of clinical research and medical practice. World Journal of Clinical Cases 2024; 12(14): 2293-2300 doi: 10.12998/wjcc.v12.i14.2293
|
| 16 |
Dario Spanu, Andrea Pretta, Eleonora Lai, Mara Persano, Clelia Donisi, Stefano Mariani, Marco Dubois, Marco Migliari, Giorgio Saba, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Giorgio Astara, Mario Scartozzi. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World Journal of Hepatology 2022; 14(7): 1319-1332 doi: 10.4254/wjh.v14.i7.1319
|
| 17 |
Yong-Bo Kang, Yue Cai. Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”. World Journal of Gastroenterology 2022; 28(20): 2248-2250 doi: 10.3748/wjg.v28.i20.2248
Abstract(718) |
Core Tip(690) |
Full Article(HTML)(2002)
|
Full Article (PDF)-629K(215)
|
Full Article (Word)-102K(110)
|
Audio-176K(3)
|
Peer-Review Report-190K(70)
|
Answering Reviewers-107K(80)
|
Times Cited (0)
|
Total Visits (6621)
|
Open
|
| 18 |
Huey-Huey Chua, Ya-Hui Chen, Li-Ling Wu, Hung-Chih Yang, Chia-Ray Lin, Huey-Ling Chen, Jia-Feng Wu, Mei-Hwei Chang, Pei-Jer Chen, Yen-Hsuan Ni. Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B. Cellular and Molecular Gastroenterology and Hepatology 2024; 17(3): 361 doi: 10.1016/j.jcmgh.2023.12.003
|
| 19 |
S Nievas, A Coniglio, W Y Takahashi, G A López, G Larama, D Torres, S Rosas, R M Etto, C W Galvão, V Mora, F Cassán. UnravelingAzospirillum’s colonization ability through microbiological and molecular evidence. Journal of Applied Microbiology 2023; 134(4) doi: 10.1093/jambio/lxad071
|
| 20 |
Min Dai, Rashid N. Lui, Louis H.S. Lau. The role of gut microbiome and fecal microbiota transplantation in liver cancer and related complications: mechanisms and therapeutic potentials. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.33
|
| 21 |
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee. The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors. Life Sciences 2022; 310: 121138 doi: 10.1016/j.lfs.2022.121138
|
| 22 |
Thomas Ryan, Sophia Ling, Andrew Trinh, Jonathan P. Segal. The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis. Best Practice & Research Clinical Gastroenterology 2024; : 101945 doi: 10.1016/j.bpg.2024.101945
|
| 23 |
Ciliang Guo, Lingkai Kong, Lingjun Xiao, Kua Liu, Huawei Cui, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu. The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01135-y
|
| 24 |
Chencheng Xie, Christine Pocha. Crosstalk between Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Disorders 2023; 5(2): 127 doi: 10.3390/gidisord5020013
|
| 25 |
Wei Xiong, Ce Yang, Jing Xia, Wenxiang Wang, Ning Li. G. lucidum triterpenes restores intestinal flora balance in non-hepatitis B virus-related hepatocellular carcinoma: evidence of 16S rRNA sequencing and network pharmacology analysis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1197418
|
| 26 |
Massimiliano Salati, Alessandro Rizzo, Angela Dalia Ricci, Angelica Petrillo, Alessandro Parisi. Principles of Immunotherapy Breast and Gastrointestinal Cancers. 2025; : 103 doi: 10.1016/B978-0-443-13376-3.00014-9
|
| 27 |
Rashmi Trivedi, Tarun Kumar Upadhyay, Mohd Adnan Kausar, Amir Saeed, Amit Baran Sharangi, Ahmad Almatroudi, Nadiyah M. Alabdallah, Mohd Saeed, Farrukh Aqil. Nanotechnological interventions of the microbiome as a next-generation antimicrobial therapy. Science of The Total Environment 2022; 833: 155085 doi: 10.1016/j.scitotenv.2022.155085
|
| 28 |
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022; 14(19): 4631 doi: 10.3390/cancers14194631
|
| 29 |
Alessandro Rizzo, Angela Dalia Ricci. Predictors of response for hepatocellular carcinoma immunotherapy: is there anything on the horizon?. Expert Review of Precision Medicine and Drug Development 2022; 7(1): 50 doi: 10.1080/23808993.2022.2075724
|
| 30 |
Suad Mohamed Ajab, Sumaya Hasan Zoughbor, Lena Abdulbaset Labania, Linda Mari Östlundh, Hiba Salaheldin Orsud, Marie Antonette Olanda, Obaid Alkaabi, Shamma Hamad Alkuwaiti, Shaikha Mohammed Alnuaimi, Zakeya Al Rasbi, Vinod Kumar Yata. Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review. PLOS ONE 2024; 19(7): e0307639 doi: 10.1371/journal.pone.0307639
|
| 31 |
Elisa Pinto, Paola Meneghel, Fabio Farinati, Francesco Paolo Russo, Filippo Pelizzaro, Martina Gambato. Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role?. Digestive and Liver Disease 2024; 56(4): 579 doi: 10.1016/j.dld.2023.08.062
|
| 32 |
Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta-Caldarola, Gennaro Palmiotti. Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology 2022; 16(4): 333 doi: 10.1080/17474124.2022.2064273
|
| 33 |
Rui Li, Junxiao Wang, Xiubin Li, Yining Liang, Yiyun Jiang, Yuwei Zhang, Pengfei Xu, Ling Deng, Zhe Wang, Tao Sun, Jian Wu, Hui Xie, Yijin Wang. T‐cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood. Cancer Science 2024; 115(1): 94 doi: 10.1111/cas.16013
|
| 34 |
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, Bixiang Zhang. Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment. Trends in Endocrinology & Metabolism 2024; 35(11): 1006 doi: 10.1016/j.tem.2024.06.003
|
| 35 |
Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies. Biomedicines 2024; 12(7): 1398 doi: 10.3390/biomedicines12071398
|
| 36 |
Yusuke Tomita, Yoshihiko Goto, Shinya Sakata, Kosuke Imamura, Ayaka Minemura, Kentaro Oka, Atsushi Hayashi, Takayuki Jodai, Kimitaka Akaike, Moriyasu Anai, Shohei Hamada, Shinji Iyama, Koichi Saruwatari, Sho Saeki, Motomichi Takahashi, Tokunori Ikeda, Takuro Sakagami. Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors. OncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2081010
|
| 37 |
Rachel Patel, Debra S. T. Chong, Alison J. Guy, Matthew Kennedy. Dialister pneumosintes and aortic graft infection – a case report. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08584-3
|
| 38 |
Ashray Gunjur, Andrea J Manrique‐Rincón, Oliver Klein, Andreas Behren, Trevor D Lawley, Sarah J Welsh, David J Adams. ‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors. The Journal of Pathology 2022; 257(4): 513 doi: 10.1002/path.5907
|
| 39 |
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy. Cell Reports Medicine 2024; 5(4): 101478 doi: 10.1016/j.xcrm.2024.101478
|